HomeAMRX • NASDAQ
add
Amneal Pharmaceuticals Inc
Previous close
$10.09
Day range
$9.91 - $10.11
Year range
$6.69 - $10.34
Market cap
3.14B USD
Avg Volume
1.68M
P/E ratio
1,145.48
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 724.51M | 3.24% |
Operating expense | 172.23M | 12.93% |
Net income | 22.42M | 273.99% |
Net profit margin | 3.09 | 263.53% |
Earnings per share | 0.25 | 56.25% |
EBITDA | 172.12M | 13.27% |
Effective tax rate | 31.14% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 75.28M | 59.45% |
Total assets | 3.42B | -2.48% |
Total liabilities | 3.47B | -1.27% |
Total equity | -46.73M | — |
Shares outstanding | 314.08M | — |
Price to book | -28.03 | — |
Return on assets | 8.25% | — |
Return on capital | 11.08% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | 22.42M | 273.99% |
Cash from operations | 83.82M | 111.36% |
Cash from investing | -26.55M | -310.63% |
Cash from financing | -41.69M | -18.81% |
Net change in cash | 15.28M | 865.81% |
Free cash flow | 41.76M | 98.47% |
About
Amneal Pharmaceuticals, Inc. is an American publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey. Wikipedia
Founded
2002
Headquarters
Website
Employees
8,300